More Conneqt Health Limited news
Conneqt Health LimitedASX: CQT

CardieX Announces Significant New Clinical Trial Agreement

Dec 9, 2022 at 1:33 AM EST · Issued by Conneqt Health Limited

Filed with ASX · Dec 9, 2022 at 1:33 AM EST · 3 pages · English

On 6ix: 6ix.com/news/cardiex-announces-significant-new-clinical-trial-agreement

Conneqt Health Limited has released a press release.

View Attachment

6ix is checking which company filed this.

Conneqt Health Limited on 6ix

Story so far

  • New Clinical Trial with Andwin, Syneos & Philip MorrisFeb 14, 2022
  • Clinical Trial Contract Expansion & Increases with Bayer AGAug 25, 2021
  • CardieX Expansion of Bayer Clinical Trial & RevenueMar 26, 2020

Earlier from Conneqt Health

  • CardieX Acquires Core Assets from Blumio, IncNov 16, 2022
  • CardieX Completes Placement & Intended Launch of SPPAug 22, 2022
  • CardieX Corporate Investor PresentationAug 18, 2022
  • CardieX Submits FDA Application for CONNEQT PulseJun 28, 2022
  • FDA Update for CONNEQT Companion AppMay 18, 2022

Later from Conneqt Health

  • CardieX Completes Capital RaisingFeb 9, 2023
  • CardieX receives FDA 510(k) Clearance for CONNEQT PulseApr 26, 2023
  • Corporate UpdateJun 29, 2023
  • Convertible Note Facility and Dual Listing UpdateJun 30, 2023
  • CardieX Files Form F-1 to Dual List on US Nasdaq ExchangeJul 26, 2023
All Conneqt Health news releases↗

Follow Conneqt Health into a list and get an email when it puts out news.

Follow Conneqt Health
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer